Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jun 16, 2010

Premium

EPEMED, an European personalized medicine association, has appointed Anne Bruinvels to be executive director and a board member. Bruinvels will work to expand the new organization and build its strategic framework.

Bruinvels has previously worked at Elixior and was CEO at Curidium, both of which are personalized healthcare companies. She also has worked in research at SmithKline Beecham, Wyeth, and Sandoz Pharma.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.